Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Ancillare’s CEO, Joanne Santomauro, Nominated for Marcum Innovator of the Year

Posted on: 20 Sep 16

Ancillare, LP’s Joanne Santomauro, Chief Executive Officer and Founder, is being recognized by Marcum LLP and Philadelphia SmartCEO as a finalist for their 2016 Marcum Innovator of the Year award.

The Marcum Innovator of the Year award honors business leaders who have developed products and services that improve the quality of life and business practice in Philadelphia. Finalists are pioneering new advancements in the biotechnology, healthcare, business services, manufacturing, real estate and technology industries. The winners will be announced on October 26, 2016 at the Sugarhouse Casino in Philadelphia, PA.

“I am honored to be recognized as a Marcum Innovator of the Year finalist. This recognition shows the dedication, support, commitment and excellence of the entire organization,” said Joanne Santomauro.

With Joanne’s forward thinking, she was able to create the ancillary supply chain management industry. Prior to the company’s launch in 2006, pharmaceutical, biotechnology and medical research organizations had little transparency and a lack of understanding of the associated costs, processes, regulatory and compliance requirements of the clinical supply chain. Over the last decade Joanne took the company to explosive growth around the world through dedication, innovative solutions including the Ancillare Turn Key Operative Model (A-TKOTM) and cutting-edge processes.

About Ancillare, LP

Ancillare, LP has extensive experience delivering cost savings and efficiencies to supply chains, with a complete turn-key approach for managing the pharmaceutical, biotechnology, contract research and medical research organizations’ clinical trial supply chains with a singular focus. Our turn-key global model (A-TKOTM) centralizes supply operations which accelerates the processes, lowers costs and mitigates risk by making clinical supply chains more efficient, cost-effective and global.

Our capabilities include pre-protocol analysis and planning, contribution to overall program feasibility assessments and timeline development, product sourcing and procurement, forecasting and budgeting, large and small equipment and consumables management, patient retention and recruitment materials, customs clearance, import/export (including IOR/EOR), storage, kitting, distribution and returns management/disposition (including destruction, refurbishment/recalibration and redeployment) on a global level.

Ancillare has managed the supply chain for top pharmaceutical and CRO organizations and has successfully transported goods to 100 countries. Ancillare has master depots in United States, United Kingdom and Singapore, and strategic depots in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan and Ukraine. To learn more, visit or contact us via LinkedIn, Twitter and Facebook.

View source version on

Business Wire

Last updated on: 20/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.